Search alternatives:
reduction changes » resolution changes (Expand Search), reduction targets (Expand Search)
changes decrease » change increases (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 121 - 140 results of 36,912 for search '(( significant ((changes decrease) OR (larger decrease)) ) OR ( significant reduction changes ))', query time: 0.88s Refine Results
  1. 121
    S1 Dataset -

    S1 Dataset - by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 122
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 123
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 124
    Pop-up for oral 3GC prescription.

    Pop-up for oral 3GC prescription. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 125
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 126
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 127
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 128
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 129
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 130
    Change in mean vehicles per day, pre- to post-pandemic, by sensor.

    Change in mean vehicles per day, pre- to post-pandemic, by sensor. by Matthew Wigginton Bhagat-Conway (16979409)

    Published 2023
    Save to List
    Saved in:
  11. 131
    Distribution of total ESs and hotspots under future climate change.

    Distribution of total ESs and hotspots under future climate change. by Bao Zhou (20670850)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 132
    Changes in tumor volume and DCE parameters.

    Changes in tumor volume and DCE parameters. by Bo Kyu Kim (18501276)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 133
    HPV16 E1 decreases cell growth.

    HPV16 E1 decreases cell growth. by Fern Baedyananda (11888703)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 134
    HFD changes lysosomal activity.

    HFD changes lysosomal activity. by Tong Yue (6033305)

    Published 2025
    Save to List
    Saved in:
  15. 135
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Save to List
    Saved in:
  16. 136
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Save to List
    Saved in:
  17. 137
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Save to List
    Saved in:
  18. 138
    Hypnotic and sedative (N05C) prescribing changes from 2014 to 2022.

    Hypnotic and sedative (N05C) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Save to List
    Saved in:
  19. 139
    Mean absolute change results of all clinical outcomes measured in diabetes related dyslipidemia.

    Mean absolute change results of all clinical outcomes measured in diabetes related dyslipidemia. by Manik Chhabra (10822587)

    Published 2022
    Save to List
    Saved in:
  20. 140
    Changes in alpha diversity in the weeks before anti-TNF-a treatment.

    Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

    Published 2024
    Save to List
    Saved in:

Search Tools: